- Home
- JSPRW vs ACCS Comparison
JSPRW vs ACCS Comparison
Compare JSPRW & ACCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPRW
- ACCS
- Stock Information
- Founded
- JSPRW N/A
- ACCS 1988
- Country
- JSPRW United States
- ACCS United States
- Employees
- JSPRW N/A
- ACCS N/A
- Industry
- JSPRW Biotechnology: Pharmaceutical Preparations
- ACCS Publishing
- Sector
- JSPRW Health Care
- ACCS Consumer Discretionary
- Exchange
- JSPRW Nasdaq
- ACCS Nasdaq
- Market Cap
- JSPRW N/A
- ACCS N/A
- IPO Year
- JSPRW N/A
- ACCS N/A
- Fundamental
- Price
- JSPRW $0.12
- ACCS $10.00
- Analyst Decision
- JSPRW
- ACCS
- Analyst Count
- JSPRW 0
- ACCS 0
- Target Price
- JSPRW N/A
- ACCS N/A
- AVG Volume (30 Days)
- JSPRW 7.8K
- ACCS 9.2K
- Earning Date
- JSPRW 03-05-2025
- ACCS 03-06-2025
- Dividend Yield
- JSPRW N/A
- ACCS N/A
- EPS Growth
- JSPRW N/A
- ACCS N/A
- EPS
- JSPRW N/A
- ACCS N/A
- Revenue
- JSPRW N/A
- ACCS $29,141,000.00
- Revenue This Year
- JSPRW N/A
- ACCS N/A
- Revenue Next Year
- JSPRW N/A
- ACCS N/A
- P/E Ratio
- JSPRW N/A
- ACCS N/A
- Revenue Growth
- JSPRW N/A
- ACCS N/A
- 52 Week Low
- JSPRW $0.15
- ACCS $7.61
- 52 Week High
- JSPRW $0.16
- ACCS $15.87
- Technical
- Relative Strength Index (RSI)
- JSPRW N/A
- ACCS N/A
- Support Level
- JSPRW N/A
- ACCS N/A
- Resistance Level
- JSPRW N/A
- ACCS N/A
- Average True Range (ATR)
- JSPRW 0.00
- ACCS 0.00
- MACD
- JSPRW 0.00
- ACCS 0.00
- Stochastic Oscillator
- JSPRW 0.00
- ACCS 0.00
About JSPRW Japer Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.